These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3356323)

  • 1. A guide to the statistical analysis of long-term carcinogenicity assays.
    McKnight B
    Fundam Appl Toxicol; 1988 Feb; 10(2):355-64. PubMed ID: 3356323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized tumor rates for chronic bioassays.
    Kodell RL; Gaylor DW; Chen JJ
    Biometrics; 1986 Dec; 42(4):867-73. PubMed ID: 3814727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Ryan LM
    Biometrics; 1985 Jun; 41(2):525-31. PubMed ID: 4027327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which rules for assembling short-term test batteries to predict carcinogenicity?
    Benigni R; Giuliani A
    Mol Toxicol; 1987; 1(2-3):143-66. PubMed ID: 3449755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Gart JJ; Tarone RE
    Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.
    Floyd E; Mann P; Long G; Ochoa R
    Toxicol Pathol; 2002; 30(1):147-56. PubMed ID: 11890468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella mutagenicity and rodent carcinogenicity: quantitative structure-activity relationships.
    Blake BW; Enslein K; Gombar VK; Borgstedt HH
    Mutat Res; 1990 Jul; 241(3):261-71. PubMed ID: 2195334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans.
    Ennever FK; Noonan TJ; Rosenkranz HS
    Mutagenesis; 1987 Mar; 2(2):73-8. PubMed ID: 3331705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term assays for carcinogenicity in animals.
    Bannasch P; Griesemer RA; Anders F; Becker R; Cabral JR; Della Porta G; Feron VJ; Henschler D; Ito N; Kroes R
    IARC Sci Publ; 1986; (83):13-83. PubMed ID: 3305341
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term assays to predict carcinogenicity. Statistical analysis of data from in-vitro assays of mutagenesis.
    Breslow N; Kaldor J
    IARC Sci Publ; 1986; (83):457-81. PubMed ID: 3305350
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical issues in the analysis of the long-term carcinogenicity bioassay in small rodents: an empirical evaluation of statistical decision rules.
    Bickis M; Krewski D
    Fundam Appl Toxicol; 1989 Feb; 12(2):202-21. PubMed ID: 2653937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies.
    Haseman JK
    Environ Health Perspect; 1984 Dec; 58():385-92. PubMed ID: 6525993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays.
    Schmezer P; Eckert C; Liegibel UM; Zelezny O; Klein RG
    Mutat Res; 1998 Sep; 405(2):193-8. PubMed ID: 9748572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.